⌘K

Login Start Free

Home/Filings/4/0001144204-19-001262

4//SEC Filing

Bright Lisa 4

Accession 0001144204-19-001262

CIK 0001270073other

View on SEC.gov Company Profile

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 8:00 PM ET

Size

4.8 KB

Accession

0001144204-19-001262

Insider Transaction Report

Form 4

Period: 2019-01-07

INTERCEPT PHARMACEUTICALS, INC.ICPT

CCO & Corp Affairs Officer

Transactions

Sale
Common Stock
2019-01-07$104.93/sh−1,313$137,773→ 18,807 total

Footnotes (1)

[F1]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.

Documents

1 file

4
tv510642_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1

filerCIK 0001635111

Filing Metadata

Form type: 4
Filed: Jan 8, 7:00 PM ET
Accepted: Jan 9, 8:00 PM ET
Size: 4.8 KB

View on SEC.gov